Search

everythinglearnresearchcommunity

for

Search:↓

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

Some drugs used to treat inflammation may cause hair loss.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

Dapsone improved pustular psoriasis in patients who didn't respond to other treatments and is considered a well-tolerated option.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Vesicular carriers like liposomes may improve cosmetic skin treatment delivery and effectiveness but need more human research.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

Lupus panniculitis of the scalp causes linear hair loss and needs ongoing treatment to prevent recurrence and lupus.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Laser-assisted drug delivery has shown improved treatment outcomes for skin conditions and has potential to reduce side effects and treatment time.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

Superficial cryotherapy is effective and safe for treating alopecia areata, with better results when used early and frequently.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Seven patients were misdiagnosed with discoid lupus instead of lichen planopilaris due to similar symptoms, showing the need for careful diagnosis in scarring hair loss conditions.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Some oral medications may help treat central serous chorioretinopathy, especially eplerenone, but more research is needed.

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.

Some cancer treatments can cause permanent hair loss.

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

SLE is rare in Uganda but often has complications and overlaps with rheumatoid arthritis.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.